Candida Infections of Medical Devices

Clinical Microbiology Reviews

Volumn 17, Issue 2, 2004, Pages 255-267

  Kojic, Erna M ^b   Darouiche, Rabih O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; BIOFILM; BRAIN VENTRICLE PERITONEUM SHUNT; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CATHETER; CATHETER INFECTION; CENTRAL VENOUS CATHETER; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; ECONOMIC ASPECT; FUNGUS ISOLATION; HEART ASSIST DEVICE; HEART VALVE PROSTHESIS; INDWELLING CATHETER; INFECTION RISK; MICROBIAL ADHESION; MUCOSA INFLAMMATION; NONHUMAN; PATHOGENESIS; PENIS PROSTHESIS; PROSTHESIS INFECTION; REVIEW;

BIOFILMS; CANDIDA; CANDIDIASIS; EQUIPMENT AND SUPPLIES; HUMANS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; FUNGI;

EID: 2042519310     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.2.255-267.2004     Document Type: Review

References (125)

1. Reference deleted.
2. Reference deleted.
3. Abi-Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24:1122-1128.
4. Anaissie, E. J., J. H. Rex, O. Uzun, and S. Vartivarian. 1998. Predictors of adverse outcome in cancer patients with candidemia. Am. J. Med. 104:238-245.
5. Anderson, J. E., A. S. Chang, and M. P. Anstadt. 2000. Polytetrafluoroethylene hemoaccess site infections. Asaio J. 46:S18-S21.
6. Arber, N., E. Pras, Y. Copperman, J. Schapiro, V. Meiner, I. Lossos, A. Militianu, D. Hassin, E. Pras, S. A., M. Moshkowitz, and Y. Sidi. 1994. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine 73:299-305.
7. Baillie, G. S., and L. J. Douglas. 1999. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48:671-679.
8. Bayer, A. S., A. F. Bolger, K. A. Taubert, W. Wilson, J. Steckelberg, A. W. Karchmer, M. Levison, H. F. Chambers, A. S. Dajani, M. H. Gewitz, J. W. Newburger, M. A. Gerber, S. T. Shulman, T. J. Pallasch, T. W. Gage, and P. Ferrieri. 1998. Diagnosis and management of infective endocarditis and its complications. Circulation 98:2936-2948.
9. Berbari, E. F., A. D. Hanssen, M. C. Duffy, J. M. Steckelberg, D. M. Ilstrup, W. S. Harmsen, and D. R. Osmon. 1998. Risk factors for prosthetic joint infection: case-control study. Clin. Infect. Dis. 27:1247-1254.
10. Bonomo, R. A., D. Rice, C. Whalen, D. Linn, E. Eckstein, and D. M. Shlaes. 1997. Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect. Control Hosp. Epidemiol. 18:757-761.
11. Bracke, F., A. Meijer, and L. van Gelder. 2000. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart 85:254-259.
12. Brant, M. D., J. K. Ludlow, and J. J. Mulcahy. 1996. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis. J. Urol. 155:155-157.
13. Brause, B. D. 1989. Prosthetic joint infections. Curr. Opin. Rheumatol. 1:194-198.
14. Cacoub, P., P. Leprince, P. Nataf, P. Hausfater, R. Dorent, B. Wechsler, V. Bors, A. Pavie, J. Piette, and I. Gandjbakhch. 1998. Paacemaker infective endocarditis. Am. J. Cardiol. 82:480-484.
15. Calderwood, S. B., L. A. Swinski, A. W. Karchmer, C. M. Waternaux, and M. J. Buckley. 1986. Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J. Thorac. Cardiovasc. Surg. 92:776-783.
16. Calderwood, S. B., L. A. Swinski, C. M. Waternaux, A. W. Karchmer, and M. J. Buckley. 1985. Risk factors for the development of prosthetic valve endocarditis. Circulation 72:31-37.
17. Carson, C. C., III. 1999. Management of prosthesis infections in urologic surgery. Urol. Clin. North Am. 26:829-839, x.
18. Carson, C. C., III, and C. N. Robertson. 1988. Late hematogenous infection of penile prostheses. J. Urol. 139:50-52.
19. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
20. Cheung, A. H., and L. M. Wong. 2001. Surgical infections in patients with chronic renal failure. Infect. Dis. Clin. North Am. 15:775-796.
21. Chua, J., B. Wilkoff, I. Lee, N. Juratli, D. Longworth, and S. Gordon. 2000. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133:604-608.
22. Cohen, T., V. Pons, J. Schwartz, and J. Griffin. 1991. Candida albicans pacemaker site infection. Pacing Clin. Electrophysiol. 14:146-148.
23. Coleman, D. C., M. G. Rinaldi, K. A. Haynes, J. H. Rex, R. C. Summerbell, E. J. Anaissie, A. Li, and D. J. Sullivan. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36:156-165.
24. Darouiche, R. O. 2001. Device-associated infections: a macroproblem that starts with microadherence. Clin. Infect. Dis. 33:1567-1572.
25. Darouiche, R. O., R. J. Hamill, D. M. Musher, E. J. Young, and R. L. Harris. 1989. Periprosthetic candidal infections following arthroplasty. Rev. Infect. Dis. 11:89-96.
26. Darouiche, R. O., I. I. Raad, S. O. Heard, J. I. Thornby, O. C. Wenker, A. Gabrielli, J. Berg, N. Khardori, H. Hanna, R. Hachem, R. L. Harris, G. Mayhall, and the Catheter Study Group. 1999. A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 340:1-8.
27. Davis, L. E. 1999. Fungal infections of the central nervous system. Neurol. Clin. 17:761-781.
28. Donlan, R. M. 2001. Biofilms and device-associated infections. Emerg. Infect. Dis. 7:277-281.
29. Donlan, R. M. 2000. Role of biofilms in antimicrobial resistance. Asaio J. 46:S47-S52.
30. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
31. Elek, S. D., and P. E. Conen. 1957. The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection. Br. J. Exp. Pathol. 38:573-586.
32. Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-421.
33. Fukasawa, N., and K. Shirakura. 1997. Candida arthritis after total knee arthroplasty - a case of successful treatment without prosthesis removal. Acta Orthop. Scand. 68:306-307.
34. Garber, B. B., and S. M. Marcus. 1998. Does surgical approach affect the incidence of inflatable penile prosthesis infection? Urology 52:291-293.
35. Geers, T. A., and S. M. Gordon. 1999. Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery. Clin. Infect. Dis. 28:1139-1147.
36. Giamarellou, H. 2002. Nosocomial cardiac infections. J. Hosp. Infect. 50: 91-105.
37. Gillespie, W. J. 1997. Prevention and management of infection after total joint replacement. Clin. Infect. Dis. 25:1310-1317.
38. Goldberg, S. P., J. W. Baddley, M. F. Aaron, P. G. Pappas, and W. L. Holman. 2000. Fungal infections in ventricular assist devices. Asaio J. 46:S37-S40.
39. Goldie, S. J., L. Kiernan-Tridle, C. Torres, N. Gorban-Brennan, D. Dunne, A. S. Kliger, and F. O. Finkelstein. 1996. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am. J. Kidney Dis. 28:86-91.
40. Gordon, S. M., S. K. Schmitt, M. Jacobs, N. M. Smedira, M. Goormastic, M. K. Banbury, M. Yeager, J. Serkey, K. Hoercher, and P. M. McCarthy. 2001. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann. Thorac. Surg. 72:725-730.
41. Harris, A. D., J. Castro, D. C. Sheppard, Y. Carmeli, and M. H. Samore. 1999. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin. Infect. Dis. 29:926-928.
42. Hawser, S. P., G. S. Baillie, and L. J. Douglas. 1998. Production of extracellular matrix by Candida albicans biofilms. J. Med. Microbiol. 47:253-256.
43. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
44. Hawser, S. P., and L. J. Douglas. 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39: 2128-2131.
45. Ivert T. S., W. E. Dismukes, C. G. Cobbs, E. H. Blackstone, J. W. Kirklin, and L. A. Bergdahl. 1984. Prosthetic valve endocarditis. Circulation 69:223-232.
46. Jacobs, L. G., E. A. Skidmore, K. Freeman, D. Lipschultz, and N. Fox. 1996. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin. Infect. Dis. 22:30-35.
47. Jarow, J. P. 1996. Risk factors for penile prosthetic infection. J. Urol. 156:402-404.
48. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
49. Joly, V., N. Belmatoug, A. Leperre, J. Robert, F. Jault, C. Carbon, and P. Yeni. 1997. Pacemaker endocarditis due to Candida albicans: case report and review. Clin. Infect. Dis. 25:1359-1362.
50. Karchmer, A. W. 2000. Infections of prosthetic valves and intravascular devices, p. 912-913. In G. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, vol. 1. Churchill Livingstone, Inc., New York, N.Y.
51. Karchmer, A. W. 1998. Salvage of infected orthopedic devices. Clin. Infect. Dis. 27:714-716.
52. Karchmer, A. W., and D. L. Longworth. 2003. Infections of intracardiac devices. Cardiol. Clin. 21:253-271, vii.
53. Kauffman, C. A., J. A. Vazquez, J. D. Sobei, H. A. Gallis, D. S. McKinsey, A. W. Karchmer, A. M. Sugar, P. K. Sharkey, G. J. Wise, R. Mangi, A. Mosher, J. Y. Lee, W. E. Dismukes, and the National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. 2000. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin. Infect. Dis. 30:14-18.
54. Kerr, C. M., J. R. Perfect, P. C. Craven, J. H. Jorgensen, D. J. Drutz, J. D. Shelburne, H. A. Gallis, and R. A. Gutman. 1983. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann. Intern. Med. 99:334-336.
55. Kremery, V., and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260.
56. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
57. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
58. Kumamoto, C. A. 2002. Candida biofilms. Curr. Opin. Microbiol. 5:608-611.
59. Kurup, A., M. Janardhan, and T. Seng. 2000. Candida tropicalis pacemaker endocarditis. J. Infect. 41:275-276.
60. Lai, K. K., and S. A. Fontecchio. 1998. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin. Infect. Dis. 27:265-269.
61. Lew, S. Q., and K. Kaveh. 2000. Dialysis access related infections. Asaio J. 46:S6-S12.
62. Lewis, R. E. 2002. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob. Agents Chemother. 46:3499-3505.
63. Li, X., Z. Yan, and J. Xu. 2003. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149:353-362.
64. Lim, E. V., and P. J. Stern. 1986. Candida infection after implant arthroplasty. A case report. J Bone Joint Surg. Am. 68:143-145.
65. Lynch, M. J., G. M. Scott, J. A. Inglis, and J. P. Pryor. 1994. Reducing the loss of implants following penile prosthetic surgery. Br. J. Urol. 73:423-427.
66. McGinnis, M. R. 1983. Detection of fungi in cerebrospinal fluid. Am. J. Med. 75:129-138.
67. Melgar, G. R., R. M. Nasser, S. M. Gordon, B. W. Lytle, T. F. Keys, and D. L. Longworth. 1997. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine (Baltimore) 76:94-103.
68. Mermel, L. A. 2001. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg. Infect. Dis. 7:197-199.
69. Mermel, L. A., B. M. Farr, R. J. Sherertz, I. I. Raad, N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Infect. Control Hosp. Epidemiol. 22: 222-242.
70. Michel, C., L. Courdavault, R. al Khayat, B. Viron, P. Roux, and F. Mignon. 1994. Fungal peritonitis in patients on peritoneal dialysis. Am. J. Nephrol. 14:113-120.
71. Miller, P. J., and R. P. Wenzel. 1987. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J. Infect. Dis. 156:471-477.
72. Minnaganti, V. R., and B. A. Cunha. 2001. Infections associated with uremia and dialysis. Infect. Dis. Clin. North Am. 15:385-406, viii.
73. Montagne, D. K. 1987. Periprosthetic infections. J. Urol. 138:68-69.
74. Montero, A., J. Romero, J. A. Vargas, C. A. Regueiro, G. Sanchez-Aloz, F. De Prados, A. De la Torre, and G. Aragon. 2000. Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir. 142:67-74.
75. Morris, A., and D. E. Low. 1999. Nosocomial bacterial meningitis, including central nervous system-shunt infections. Infect. Dis. Clin. North Am. 13: 735-750.
76. Mulcahy, J. J. 2000. Long-term experience with salvage of infected penile implants. J. Urol. 163:481-482.
77. Murphy, K., J. Bradley, and H. E. James. 2000. The treatment of Candida albicans shunt infections. Childs Nerv. Syst. 16:4-7.
78. Myers, T. J., T. Khan, and O. H. Frazier. 2000. Infectious complications associated with ventricular assist systems. Asaio J. 46:S28-S36.
79. Nasser, R. M., G. R. Melgar, D. L. Longworth, and S. M. Gordon. 1997. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am. J. Med. 103:25-32.
80. Nassoura, Z., R. R. Ivatury, R. J. Simon, N. Jabbour, and W. M. Stahl. 1993. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J. Trauma 35:290-294, discussion 294-295.
81. National Nosocomial Infections Surveillance System. 2001. NNIS System report. Data summary from January 1992-June 2001, issue August 2001. J. Infect. Control 29:404-420.
82. Nguyen, M. H., M. L. Nguyen, V. L. Yu, D. McMahon, T. F. Keys, and M. Amidi. 1996. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin. Infect. Dis. 22:262-267.
83. Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
84. Nguyen, M. H., and V. L. Yu. 1995. Meningitis caused by Candida species: an emerging problem in neurosurgical patients. Clin. Infect. Dis. 21:323-327.
85. Nguyen, M. H., V. L. Yu, and A. J. Morris. 1996. Candida infection of the arteriovenous fistula used for hemodialysis. Am. J. Kidney Dis. 27:596-598.
86. Nucci, M., and E. Anaissie. 2001. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis. 33:1959-1967.
87. Nucci, M., and E. Anaissie. 2002. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin. Infect. Dis. 34:591-599.
88. Peppas, D. S., J. W. Moul, and D. G. McLeod. 1988. Candida albicans corpora abscess following penile prosthesis placement. J. Urol. 140:1541-1542.
89. Platt, R., B. F. Polk, B. Murdoch, and B. Rosner. 1986. Risk factors for nosocomial urinary tract infection. Am. J. Epidemiol. 124:977-985.
90. Potera, C. 1999. Forging a link between biofilms and disease. Science 283:1837, 1839.
91. Raad, I., and G. P. Bodey. 1992. Infectious complications of indwelling vascular catheters. Clin. Infect. Dis. 15:197-210.
92. Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
93. Ramage, G., K. Vande Walle, S. P. Bachmann, B. L. Wickes, and J. L. Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.
94. Ramamohan, N., N. Zeineh, P. Grigoris, and I. Butcher. 2001. Candida glabrata infection after total hip arthroplasty. J. Infect. 42:74-76.
95. Reagan, D. R., M. A. Pfaller, R. J. Hollis, and R. P. Wenzel. 1990. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J. Clin. Microbiol. 28:2733-2738.
96. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. van der Horst, J. E. Edwards, R. G. Washburn, W. M. Scheid, A. W. Karchmer, A. P. Dine, et al. for the Candidemia Study Group and the National Institute. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325-1330.
97. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
98. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 2000. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 21:510-515.
99. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27: 887-892.
100. Roger, P., C. Boissy, M. Gary-Toussaint, R. Foucher, V. Mondain, F. Vandenbos, Y. Le Fichoux, J. Michels, and P. Dellamonica. 2000. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata. J. Infect. 41:176-194.
101. Sanchez-Portocarrero, J., P. Martin-Rabadan, C. J. Saldana, and E. Perez-Cecilia. 1994. Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn. Microbiol. Infect. Dis. 20: 33-40.
102. Seelig, M. S., C. P. Speth, P. J. Kozinn, C. L. Taschdjian, E. F. Toni, and P. Goldberg. 1974. Patterns of Candida endocarditis following cardiac surgery: importance of early diagnosis and therapy (an analysis of 91 cases). Prog. Cardiovasc. Dis. 17:125-160.
103. Segreti, J., J. A. Nelson, and G. M. Trenholme. 1998. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin. Infect. Dis. 27:711-713.
104. Shapiro, S., T. Javed, and J. Mealey, Jr. 1989. Candida albicans shunt infection. Pediatr. Neurosci. 15:125-130.
105. Shin, J. H., S. J. Kee, M. G. Shin, S. H. Kim, D. H. Shin, S. K. Lee, S. P. Suh, and D. W. Ryang. 2002. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of blood-stream isolates with isolates from other sources. J. Clin. Microbiol. 40:1244-1248.
106. Smego, R. A., Jr., J. R. Perfect, and D. T. Durack. 1984. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev. Infect. Dis. 6:791-801.
107. Sobel, J. D., C. A. Kauffman, D. McKinsey, M. Zervos, J. A. Vazquez, A. W. Karchmer, J. Lee, C. Thomas, H. Panzer, W. E. Dismukes, and The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. 2000. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin. Infect. Dis. 30:19-24.
108. Soto-Hernandez, J. L., M. A. Ramirez-Crescencio, V. M. Moreno Estrada, and R. del Valle Robles. 2000. Candida albicans cerebral granulomas associated with a nonfunctional cerebrospinal fluid shunt: case report. Neurosurgery 47:973-976, discussion 976-977.
109. Spinler, S. A., J. J. Nawarskas, E. F. Foote, D. Sabapathi, J. E. Connors, and F. E. Marchlinski. 1998. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center. Clin. Infect. Dis. 26:1111-1116.
110. Stocks, G., and H. F. Janssen. 2000. Infection in patients after implantation of an orthopedic device. Asaio J. 46:S41-S46.
111. Tacconelli, E., M. Tumbarello, M. Pittiruti, F. Leone, M. B. Lucia, R. Cauda, and L. Ortona. 1997. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:203-209.
112. Trappe, H. J., P. Pfitzner, H. Klein, and P. Wenzlaff. 1995. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br. Heart J. 73:20-24.
113. Tsukayama, D. T., R. Estrada, and R. B. Gustilo. 1996. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J. Bone Joint Surg. Am. 78:512-523.
114. Turnier, E., J. H. Kay, S. Bernstein, A. M. Mendez, and P. Zubiate. 1975. Surgical treatment of Candida endocarditis. Chest 67:262-268.
115. Turowski, G. A., D. P. Orgill, J. J. Pribaz, E. Eriksson, and G. S. Couper. 1998. Salvage of externally exposed ventricular assist devices. Plast. Reconstr. Surg. 102:2425-2430.
116. Vas, S., and D. G. Oreopoulos. 2001. Infections in patients undergoing peritoneal dialysis. Infect. Dis. Clin. North Am. 15:743-774.
117. Victor, F., C. De Place, C. Camus, H. Le Breton, C. Leclercq, D. Pavin, P. Mabo, and C. Daubert. 1999. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 81:82-87.
118. Voss, A., R. J. Hollis, M. A. Pfaller, R. P. Wenzel, and B. N. Doebbeling. 1994. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J. Clin. Microbiol. 32:975-980.
119. Wang, A. Y., A. W. Yu, P. K. Li, P. K. Lam, C. B. Leung, K. N. Lai, and S. F. Lui. 2000. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am. J. Kidney Dis. 36:1183-1192.
120. Wenzel, R. P. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20:1531-1534.
121. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149:2349-2353.
122. Wilhelm, M., C. Schmid, D. Hammel, S. Kerber, H. Loick, M. Herrmann, and H. Scheid. 1997. Cardiac pacemaker infection: surgical management with and without extracorporeal circulation. Ann. Thorac. Surg. 64:1707-1712.
123. Yamada, M., S. Takeuchi, Y. Shiojiri, K. Maruta, A. Oki, K. Iyano, and T. Takaba. 2002. Surgical lead-preserving procedures for pacemaker pocket infection. Ann. Thorac. Surg. 74:1494-1499.
124. Yu, V. L., G. D. Fang, T. F. Keys, A. A. Harris, L. O. Gentry, P. C. Fuchs, M. M. Wagener, and E. S. Wong. 1994. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann. Thorac. Surg. 58:1073-1077.
125. Zimmerli, W., and P. E. Ochsner. 2002. Management of infection associated with prosthetic joints. Infection 31:99-108.